Filing Details

Accession Number:
0001358403-19-000111
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-23 16:03:58
Reporting Period:
2019-08-21
Accepted Time:
2019-08-23 16:03:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358403 Bellicum Pharmaceuticals Inc BLCM Pharmaceutical Preparations (2834) 201450200
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695851 A. Richard Fair 2130 West Holcombe Blvd.
Ste.800
Houston TX 77030
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-21 20,000 $0.99 26,561 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9855 to $0.995, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Includes 6,561 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan.